California State Teachers Retirement System (CalSTRS)’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.04M Buy
+128,346
New +$3.17M 0.01% 966
2026
Q1
Sell
-58,383
Closed -$782K 3006
2025
Q4
$782K Buy
58,383
+1,092
+2% +$13.5K ﹤0.01% 1900
2025
Q3
$675K Buy
57,291
+3
+0% +$28 ﹤0.01% 1965
2025
Q2
$372K Sell
57,288
-1,210
-2% -$7.96K ﹤0.01% 2160
2025
Q1
$342K Hold
58,498
﹤0.01% 2197
2024
Q4
$407K Buy
58,498
+14
+0% +$96 ﹤0.01% 2199
2024
Q3
$333K Buy
58,484
+2,184
+4% +$15.2K ﹤0.01% 2273
2024
Q2
$406K Buy
+56,300
New +$492K ﹤0.01% 2185
2022
Q2
Sell
-9,198
Closed -$153K 3245
2022
Q1
$153K Sell
9,198
-3,340
-27% -$57.9K ﹤0.01% 2736
2021
Q4
$260K Sell
12,538
-42
-0.3% -$1.34K ﹤0.01% 2706
2021
Q3
$440K Sell
12,580
-17,038
-58% -$737K ﹤0.01% 2499
2021
Q2
$1.53M Buy
+29,618
New +$1.55M ﹤0.01% 1931

Other funds holding DFTX

California State Teachers Retirement System (CalSTRS)'s DFTX Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 128,346 shares worth $6.04M. The stake represents 0.01% of the portfolio and ranks #966 among its holdings. This is a return to the name: California State Teachers Retirement System (CalSTRS) previously reported a position in DFTX as recently as Q4 2025.

California State Teachers Retirement System (CalSTRS) first reported a position in DFTX in Q2 2021 and has held it in 12 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 128,346 shares of Definium Therapeutics worth $6.04M as of Q2 2026.
  • Definium Therapeutics was a new California State Teachers Retirement System (CalSTRS) position in Q2 2026.
  • Definium Therapeutics made up 0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #966 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Definium Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.